Acrivon Therapeutics, Inc. (ACRV) Tops Q3 EPS by 15c

Acrivon Therapeutics, Inc. (NASDAQ: ACRV) reported Q3 EPS of ($0.59), $0.15 better than the analyst estimate of ($0.74).

For earnings history and earnings-related data on Acrivon Therapeutics, Inc. (ACRV) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Home Depot (HD) call put ratio 1.5 calls to 1 put with a focus on September 330 puts into quarter results
• Star Equity Holdings (STRR) Misses Q2 EPS by 8c